The 3 Small CRISPR Biotechs That Could Cure 10,000 Diseases Post author:Sam Post published:February 4, 2018 Post category:BioPharma A look at three small biotech companies that appear to be leading the CRISPR race. Source: BioSpace You Might Also Like How Roche Fine-Tuned an Old Drug Under a New Name to Keep Making Profits August 23, 2017 OSE Immunotherapeutics Announces Strategic Multi-Year Research Collaboration With Memorial Sloan-Kettering Cancer Center In New York June 11, 2017 Struggling MannKind's New Strategy Includes Doubling Its Sales Force January 18, 2017
OSE Immunotherapeutics Announces Strategic Multi-Year Research Collaboration With Memorial Sloan-Kettering Cancer Center In New York June 11, 2017
